DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo

ViroPharma, Inc.

NASDAQ: VPHM

0.00 0.00 (0.00%)

Quote as of


company name or ticker

Recent Quotes

VPHM $0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $23.13 - $50.01
Market Cap $0.00
P/E Ratio 1,665.33
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS -$0.78

Sector

Healthcare

Industry

Drugs

ViroPharma, Inc. (VPHM) Description

A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings. Website: http://www.viropharma.com/

News & Commentary Rss Feed

Prem Watsa Cuts One of His 'Most Successful Investments'

Bearish Canadian Investor Prem Watsa's 7 New Positions

Why Did Billionaire Mario Gabelli's Company Buy Diebold, Responsys, and ViroPharma?

We small investors can get promising ideas from big investors.

Mario Gabelli's Top 5 Fourth-Quarter Stock Buys

Why 2014 Could Be a Huge Year for M&A Activity

With 2014 less than a month old, there have been several major deals already. However, there could be more to come.

Shire Sells Dermagraft - Analyst Blog

Shire Quickly Pulls Off Dermagraft

Solid 2014 Expected for Shire - Analyst Blog

Small-Cap Growth Stocks: A Long-Term Winning Investment

This investment focused on small-cap growth stocks has trounced the S&P 500 over time.

Understanding Zerenex's Patent Protection And Latest Issuance

See More VPHM News...

VPHM's Top Competitors

VPHM $0.00 (0.00%)
Current stock: VPHM
JNJ $98.96 (0.21%)
Current stock: JNJ
PFE $30.25 (0.53%)
Current stock: PFE
RHHBY $36.22 (0.14%)
Current stock: RHHBY